Meloxicam, an inhibitor of cyclooxygenase-2, increases the level of serum G-CSF and might be usable as an auxiliary means in G-CSF therapy.

@article{Hofer2008MeloxicamAI,
  title={Meloxicam, an inhibitor of cyclooxygenase-2, increases the level of serum G-CSF and might be usable as an auxiliary means in G-CSF therapy.},
  author={Michal Hofer and Miloslav Posp{\'i}{\vs}il and Vladim{\'i}r Znojil and Jirina Hol{\'a} and Anton{\'i}n Vacek and Denisa Streitov{\'a}},
  journal={Physiological research},
  year={2008},
  volume={57 2},
  pages={307-10}
}
Hematopoiesis-modulating action of meloxicam, a cyclooxyge-nase-2 inhibitor, has been evaluated in mice. Increased serum level of granulocyte colony-stimulating factor (G-CSF) after meloxicam administration has been found in sublethally gamma-irradiated animals. In further experiments hematopoiesis-stimulating effects of meloxicam and G-CSF given alone or in combination have been investigated. Granulocyte/macrophage progenitor cells counts were used to monitor these effects. Meloxicam and… CONTINUE READING
Highly Cited
This paper has 18 citations. REVIEW CITATIONS